The Journal of Experimental Medicine · 2008 · 92 citations · 25 references
Life SciencesBiochemistryMolecular BiologyProtein BiochemistryProtein EngineeringProtein-protein InteractionsImmunoregulation In Parasitic InfectionLipoprotein AnalysisApolipoprotein FunctionTransgenic AnimalsTransgenic MiceTreatment Of TrypanosomiasisTrypanosomatid-host InteractionsTrypanosome InfectionsTrypanosomiasis Pathogenesis
Humans express a unique subset of high-density lipoproteins (HDLs) called trypanosome lytic factors (TLFs) that kill many Trypanosoma parasite species. The proteins apolipoprotein (apo) A-I, apoL-I, and haptoglobin-related protein, which are involved in TLF structure and function, were expressed through the introduction of transgenes in mice to explore their physiological roles in vivo. Transgenic expression of human apolipoprotein L-I alone conferred trypanolytic activity in vivo. Coexpression of human apolipoprotein A-I and haptoglobin-related protein (Hpr) had an effect on the integration of apolipoprotein L-I into HDL, and both proteins were required to increase the specific activity of TLF, which was measurable in vitro. Unexpectedly, truncated apolipoprotein L-I devoid of the serum resistance gene interacting domain, which was previously shown to kill human infective trypanosomes, was not trypanolytic in transgenic mice despite being coexpressed with human apolipoprotein A-I and Hpr and incorporated into HDLs. We conclude that all three human apolipoproteins act cooperatively to achieve maximal killing capacity and that truncated apolipoprotein L-I does not function in transgenic animals.
25
Apolipoprotein L-I is the trypanosome lytic factor of human serum
Luc Vanhamme, Françoise Paturiaux-Hanocq, Philippe Poelvoorde et al. · Nature · 2003 · 495 citations
E M Rubin, Brian Y. Ishida, S Clift et al. · Proceedings of the National Academy of Sciences · 1991 · 273 citations